Researcher profile · Semantic Scholar

Ritu Ojha

h-index: 15
Works: 26
Citations: 670

Most-cited papers

An updated patent review: xanthine oxidase inhibitors for the treatment of hyperuricemia and gout (2011-2015)
Ritu Ojha, Jagjeet Singh, A. Ojha, H. Singh +2 more
2017Expert Opinion on Therapeutic Patents87 citations
Semantic Scholar
Vasicine and structurally related quinazolines
Kunal Nepali, Sahil Sharma, Ritu Ojha, K. Dhar
2013Medicinal Chemistry Research63 citations
Semantic Scholar
Design strategies, structure activity relationship and mechanistic insights for purines as kinase inhibitors.
Sahil Sharma, Jagjeet Singh, Ritu Ojha, H. Singh +3 more
2016European journal of medicinal chemistry57 citations Open access
Semantic Scholar
Steering the antitumor drug discovery campaign towards structurally diverse indolines.
Amandeep Thakur, Arshdeep Singh, N. Kaur, Ritu Ojha +1 more
2019Bioorganic chemistry (Print)53 citations
Semantic Scholar
Synthesis and evaluation of naphthoflavones as a new class of non purine xanthine oxidase inhibitors.
H. Singh, Sahil Sharma, Ritu Ojha, M. Gupta +2 more
2014Bioorganic & Medicinal Chemistry Letters47 citations
Semantic Scholar
Microwave assisted synthesis of naphthopyrans catalysed by silica supported fluoroboric acid as a new class of non purine xanthine oxidase inhibitors.
Sahil Sharma, K. Sharma, Ritu Ojha, Dinesh Kumar +3 more
2014Bioorganic & Medicinal Chemistry Letters44 citations Open access
Semantic Scholar
1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC.
Ritu Ojha, Han-Li Huang, Wei-Chun HuangFu, Yi-Wen Wu +7 more
2018European journal of medicinal chemistry43 citations Open access
Semantic Scholar
Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo.
Ritu Ojha, Kunal Nepali, Chun-Han Chen, Kuo-Hsiang Chuang +11 more
2020European journal of medicinal chemistry36 citations Open access
Semantic Scholar
Installation of Pargyline, a LSD1 Inhibitor, in the HDAC Inhibitory Template Culminated in the Identification of a Tractable Antiprostate Cancer Agent.
Ritu Ojha, I-Chung Chen, Chien-Ming Hsieh, Kunal Nepali +6 more
2021Journal of Medicinal Chemistry34 citations Open access
Semantic Scholar
Early investigational tubulin inhibitors as novel cancer therapeutics
Kunal Nepali, Ritu Ojha, Hsueh-Yun Lee, J. Liou
2016Expert Opinion on Investigational Drugs34 citations
Semantic Scholar
1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase.
Mei-Jung Lai, Ritu Ojha, Mei-Hsiang Lin, Yi-Min Liu +8 more
2019European journal of medicinal chemistry33 citations Open access
Semantic Scholar
Tubulin inhibitors: a patent survey.
Kunal Nepali, Ritu Ojha, Sahil Sharma, P. Bedi +1 more
2014Recent Patents on Anti-Cancer Drug Discovery29 citations
Semantic Scholar
4,6‐Diaryl/heteroarylpyrimidin‐2(1H)‐ones as a New Class of Xanthine Oxidase Inhibitors
Shiwani Shukla, Dinesh Kumar, Ritu Ojha, M. Gupta +2 more
2014Archiv der Pharmazie27 citations
Semantic Scholar
Ring-opened tetrahydro-γ-carbolines display cytotoxicity and selectivity with histone deacetylase isoforms.
Kunal Nepali, Hsueh-Yun Lee, Mei-Jung Lai, Ritu Ojha +4 more
2017European journal of medicinal chemistry26 citations Open access
Semantic Scholar
Effect of ring A and ring B substitution on the cytotoxic potential of pyrazole tethered chalcones
Kunal Nepali, Kanika Kadian, Ritu Ojha, Rajni Dhiman +5 more
2012Medicinal Chemistry Research25 citations
Semantic Scholar
Design, Synthesis and Evaluation of Arylidene Pyrrolo and Pyrido Fused Quinazolones as Antimicrobial Agents
Kunal Nepali, Ritu Ojha, Aninder Singh, A. Budhiraja +2 more
20138 citations
Semantic Scholar
Estimation of Seasonal Variation of Two Major Pyrrolo [2,1-b] Quinazoline Alkaloids of Adhatoda vasica by HPLC
S. Patil, Ritu Ojha, G. Kaur, Kunal Nepali +2 more
20136 citations
Semantic Scholar
Aza analogs of flavones as potential antimicrobial agents
Sahil Sharma, V. Thakur, Ritu Ojha, A. Budhiraja +2 more
20135 citations
Semantic Scholar
Anticancer Agents Targeting Tubulin
Ritu Ojha, Sahil Sharma, Kunal Nepali
20154 citations
Semantic Scholar
Inflammation and carcinogenesis: molecular targets and small-molecule intervention strategies
Wan-Jung Lu, Ritu Ojha, Mandeep Rana, Vinod Gautam +2 more
2026Journal of Enzyme Inhibition and Medicinal Chemistry3 citations Open access
Semantic Scholar
Preparation, Characterization and Optimization of Poloxamer Solid Dispersions of a Poorly Water Soluble Drug Aprepitant
R. Dhillon, Ritu Ojha, Neena Bedi
20143 citations Open access
Semantic Scholar
Synthesis, In Vitro Hydrolysis, Bioanalytical Method Development and Pharmacokinetic Study of an Amide Prodrug of Ibuprofen
Ritu Ojha, Kunal Nepali, R. Goyal, K. Dhar +1 more
20122 citations
Semantic Scholar
Corrigendum to"Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo"[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086].
Ritu Ojha, Kunal Nepali, Chun-Han Chen, Kuo-Hsiang Chuang +11 more
2020European journal of medicinal chemistry1 citations
Semantic Scholar
Vasicine and structurally related quinazolines
Kunal Nepali, Sahil Sharma, Ritu Ojha, K. Dhar
2012Medicinal Chemistry Research1 citations
Semantic Scholar
Palladium-catalysed synthesis of small-molecule epigenetic inhibitors as anticancer therapeutics
Ram Sharma, Mandeep Rana, Amandeep Thakur, Ritu Ojha +3 more
2026Journal of Enzyme Inhibition and Medicinal Chemistry0 citations
Semantic Scholar
Effect of ring A and ring B substitution on the cytotoxic potential of pyrazole tethered chalcones
Kunal Nepali, Kanika Kadian, Ritu Ojha, Rajni Dhiman +5 more
2011Medicinal Chemistry Research0 citations
Semantic Scholar

×7

T. Lin×4

H. Singh×3